A Multicenter Phase II Trial of mFOLFOX6 Plus Bevacizumab to Treat Liver-Only Metastases of Colorectal Cancer that are Unsuitable for Upfront Resection (TRICC0808)

被引：0

作者：

Hiroyuki Uetake

Masamichi Yasuno

Megumi Ishiguro

Shingo Kameoka

Yasuhiro Shimada

Keiichi Takahashi

Toshiaki Watanabe

Kei Muro

Hideo Baba

Junji Yamamoto

Nobuyuki Mizunuma

Hiroshi Tamagawa

Izumi Mochizuki

Yusuke Kinugasa

Takashi Kikuchi

Kenichi Sugihara

机构：

[1] Tokyo Medical and Dental University,Department of Translational Oncology, Graduate School

[2] Tokyo Metropolitan Hiroo Hospital,Department of Surgery

[3] Tokyo Women’s Medical University,Department of Surgery II

[4] National Cancer Center Hospital,Division of Gastrointestinal Medical Oncology

[5] Tokyo Metropolitan Cancer and Infectious Disease Center,Colorectal Surgical Division, Department of Surgery

[6] Komagome Hospital,Department of Surgical Oncology, Graduate School of Medicine

[7] The University of Tokyo,Clinical Oncology

[8] Aichi Cancer Center Hospital,Department of Gastroenterological Surgery, Graduate School of Medical Science

[9] Kumamoto University,Department of Surgery

[10] National Defense Medical College,Gastroenterological Center

[11] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Surgery

[12] Osaka General Medical Center,Department of Surgery

[13] Iwate Prefectural Central Hospital,Gastrointestinal Surgery Division

[14] Shizuoka Cancer Center,Department of Statistical Analysis

[15] Translational Research Informatics Center,Department of Surgery Oncology

[16] Tokyo Medical and Dental University,undefined

来源：

Annals of Surgical Oncology | 2015年 / 22卷

关键词：

Bevacizumab; Liver Metastasis; Sixth Cycle; Resectable Liver Metastasis; High Adverse Event;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：908 / 915

页数：7

共 35 条

[21] A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only [J].

Bendell, Johanna C. ;

Zakari, Ahmed ;

Peyton, James D. ;

Boccia, Ralph ;

Moskowitz, Mark ;

Gian, Victor ;

Lipman, Andrew ;

Waterhouse, David ;

LoCicero, Richard ;

Earwood, Chris ;

Lane, Cassie M. ;

Meluch, Anthony .

ONCOLOGIST, 2016, 21 (03) :279-280

[22] Raltitrexed Chemotherapy Regimen Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer: A Prospective Multicenter Phase II Trial [J].

Li, Sheng ;

Li, Xiaoyou ;

Zhu, Qianni ;

Gao, Jin ;

Zhu, Chunrong ;

Zhu, Liangjun .

CANCER CONTROL, 2024, 31

[23] Trifluridine/tipiracil plus bevacizumab as a first-line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial [J].

Oki, Eiji ;

Makiyama, Akitaka ;

Miyamoto, Yuji ;

Kotaka, Masahiko ;

Kawanaka, Hirofumi ;

Miwa, Keisuke ;

Kabashima, Akira ;

Noguchi, Tomohiro ;

Yuge, Kotaro ;

Kashiwada, Tomomi ;

Ando, Koji ;

Shimokawa, Mototsugu ;

Saeki, Hiroshi ;

Akagi, Yoshito ;

Baba, Hideo ;

Maehara, Yoshihiko ;

Mori, Masaki .

CANCER MEDICINE, 2021, 10 (02) :454-461

[24] A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases [J].

Feng, Ai-Wei ;

Guo, Jian-Hai ;

Gao, Song ;

Kou, Fu-Xin ;

Liu, Shao-Xing ;

Liu, Peng ;

Chen, Hui ;

Wang, Xiao-Dong ;

Xu, Hai-Feng ;

Cao, Guang ;

Zhu, Xu .

FRONTIERS IN ONCOLOGY, 2022, 12

[25] Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial [J].

Ychou, Marc ;

Rivoire, Michel ;

Thezenas, Simon ;

Guimbaud, Rosine ;

Ghiringhelli, Francois ;

Mercier-Blas, Anne ;

Mineur, Laurent ;

Francois, Eric ;

Khemissa, Faiza ;

Chauvenet, Marion ;

Kianmanesh, Reza ;

Fonck, Marianne ;

Houyau, Philippe ;

Aparicio, Thomas ;

Galais, Marie-Pierre ;

Audemar, Franck ;

Assenat, Eric ;

Lopez-Crapez, Evelyne ;

Jouffroy, Claire ;

Adenis, Antoine ;

Adam, Rene ;

Bouche, Olivier .

BRITISH JOURNAL OF CANCER, 2022, 126 (09) :1264-1270

[26] A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment [J].

Nikol Snoeren ;

Emile E Voest ;

Andre M Bergman ;

Otilia Dalesio ;

Henk M Verheul ;

Rob AEM Tollenaar ;

Joost RM van der Sijp ;

Sander B Schouten ;

Inne HM Borel Rinkes ;

R van Hillegersberg .

BMC Cancer, 10

[27] Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer [J].

Stefan Madajewicz ;

David M. Waterhouse ;

Paul S. Ritch ;

M. Qaseem Khan ;

Donald J. Higby ;

Cynthia G. Leichman ;

Sandeep K. Malik ;

Patricia Hentschel ;

John F. Gill ;

Luping Zhao ;

Steven J. Nicol .

Investigational New Drugs, 2012, 30 :772-778

[28] Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer [J].

Madajewicz, Stefan ;

Waterhouse, David M. ;

Ritch, Paul S. ;

Khan, M. Qaseem ;

Higby, Donald J. ;

Leichman, Cynthia G. ;

Malik, Sandeep K. ;

Hentschel, Patricia ;

Gill, John F. ;

Zhao, Luping ;

Nicol, Steven J. .

INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) :772-778

[29] Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002) [J].

Oki, Eiji ;

Emi, Yasunori ;

Miyamoto, Yuji ;

Kabashima, Akira ;

Higashi, Hidefumi ;

Ogata, Yutaka ;

Ikebe, Masahiko ;

Saeki, Hiroshi ;

Tokunaga, Shoji ;

Shirabe, Ken ;

Beppu, Toru ;

Uchida, Shinji ;

Takatsuki, Mitsuhisa ;

Sakoda, Masahiko ;

Eguchi, Susumu ;

Akagi, Yoshito ;

Kakeji, Yoshihiro ;

Baba, Hideo ;

Natsugoe, Shoji ;

Maehara, Yoshihiko .

ANNALS OF SURGICAL ONCOLOGY, 2015, 22 :S1067-S1074

[30] Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002) [J].

Eiji Oki ;

Yasunori Emi ;

Yuji Miyamoto ;

Akira Kabashima ;

Hidefumi Higashi ;

Yutaka Ogata ;

Masahiko Ikebe ;

Hiroshi Saeki ;

Shoji Tokunaga ;

Ken Shirabe ;

Toru Beppu ;

Shinji Uchida ;

Mitsuhisa Takatsuki ;

Masahiko Sakoda ;

Susumu Eguchi ;

Yoshito Akagi ;

Yoshihiro Kakeji ;

Hideo Baba ;

Shoji Natsugoe ;

Yoshihiko Maehara .

Annals of Surgical Oncology, 2015, 22 :1067-1074

← 1 2 3 4 →